It’s not surprising to learn that 48% of all US biotech IPOs occurred in the state of MA in 2017! Though it is still quite an impressive figure. As the money continues to pour in, the jobs will continue to open up. Source: The booming Boston/Cambridge biotech hub claims an industry-leading role — nobody beats […]
Industry News
The booming Boston/Cambridge biotech hub claims an industry-leading role… Endpoints News
August 30th, 2018 | Industry NewsTrial run: Biotech firms are racing to new clusters outside of Cambridge
August 27th, 2018 | Industry NewsThe geographical expansion of the biotech industry in MA is a breath of fresh air! As traffic increases and open space decreases in Cambridge/Boston, we can certainly welcome a more diverse and widespread range of locational options as the industry continues to grow. Sounds like a win-win to us! Trial run: Biotech firms are racing […]
FDA decision looming, Alnylam plans to double staff, triple Kendall Square footprint – Boston Business Journal
August 7th, 2018 | Industry NewsMarket Conditions Remain Strong
May 3rd, 2018 | Industry NewsVirtual companies answer demand for better quality of life
April 5th, 2018 | Industry NewsThe delta between supply and demand for talent in the biotech and pharma industry has never been wider, particularly in heavily populated, tightly congested marketplaces such as Boston and the Bay Area. Remote/work-from-home provisions must be given serious consideration by employers in order to help bridge that delta. We have seen incremental increases in such […]